High-resolution chromosomal microarray analysis of early-stage human embryonic stem cells reveals an association between X chromosome instability and skewed X inactivation

Cell and Bioscience

Volumn 4, Issue 1, 2014, Pages

  Luo, Yumei ^a   Li, Jieliang ^a   Zhu, Detu ^a   Fan, Yong ^a   Li, Shaoying ^a   Sun, Xiaofang ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Chromosomal microarray analysis; Genome instability; Human embryonic stem cells; Skewed X chromosome inactivation

Indexed keywords

EID: 85027922101     PISSN: None     EISSN: 20453701     Source Type: Journal    
DOI: 10.1186/2045-3701-4-74     Document Type: Article

References (29)

1. de Mello JC M, de Araujo ES, Stabellini R, Fraga AM, de Souza JE, Sumita DR, Camargo AA, Pereira LV: Random X inactivation and extensive mosaicism in human placenta revealed by analysis of allele-specific gene expression along the X chromosome. PLoS One 2010, 5:e10947. 10.1371/journal.pone.0010947
2. Kristiansen M, Langerod A, Knudsen GP, Weber BL, Borresen-Dale AL, Orstavik KH: High frequency of skewed X inactivation in young breast cancer patients. J Med Genet 2002, 39:30-33. 10.1136/jmg.39.1.30
3. Bretherick K, Gair J, Robinson WP: The association of skewed X chromosome inactivation with aneuploidy in humans. Cytogenet Genome Res 2005, 111:260-265. 10.1159/000086898
4. Zhu D, Chen C, Purwanti YI, Du S, Lam DH, Wu C, Zeng J, Toh HC, Wang S: Induced pluripotent stem cell-derived neural stem cells transduced with baculovirus encoding CD40 ligand for immunogene therapy in mouse models of breast cancer. Hum Gene Ther 2014, 25:747-758. 10.1089/hum.2013.160
5. Ozbalkan Z, Bagislar S, Kiraz S, Akyerli CB, Ozer HT, Yavuz S, Birlik AM, Calguneri M, Ozcelik T: Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum 2005, 52:1564-1570. 10.1002/art.21026
6. Luo Y, Zhu D: Combinatorial control of transgene expression by hypoxia-responsive promoter and microrna regulation for neural stem cell-based cancer therapy. Biomed Res Int 2014, 2014:751397.
7. Zhu D, Lam DH, Purwanti YI, Goh SL, Wu C, Zeng J, Fan W, Wang S: Systemic delivery of fusogenic membrane glycoprotein-expressing neural stem cells to selectively kill tumor cells. Mol Ther 2013, 21:1621-1630. 10.1038/mt.2013.123
8. Vallot C, Huret C, Lesecque Y, Resch A, Oudrhiri N, Bennaceur-Griscelli A, Duret L, Rougeulle C: XACT, a long noncoding transcript coating the active X chromosome in human pluripotent cells. Nat Genet 2013, 45:239-241. 10.1038/ng.2530
9. Okamoto I, Patrat C, Thepot D, Peynot N, Fauque P, Daniel N, Diabangouaya P, Wolf JP, Renard JP, Duranthon V, Heard E: Eutherian mammals use diverse strategies to initiate X-chromosome inactivation during development. Nature 2011, 472:370-374. 10.1038/nature09872
10. Shen Y, Matsuno Y, Fouse SD, Rao N, Root S, Xu R, Pellegrini M, Riggs AD, Fan G: X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations. Proc Natl Acad Sci U S A 2008, 105:4709-4714. 10.1073/pnas.0712018105
11. Silva SS, Rowntree RK, Mekhoubad S, Lee JT: X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells. Proc Natl Acad Sci U S A 2008, 105:4820-4825. 10.1073/pnas.0712136105
12. Dvash T, Lavon N, Fan G: Variations of X chromosome inactivation occur in early passages of female human embryonic stem cells. PLoS One 2010, 5:e11330. 10.1371/journal.pone.0011330
13. Cotton AM, Ge B, Light N, Adoue V, Pastinen T, Brown CJ: Analysis of expressed SNPs identifies variable extents of expression from the human inactive X chromosome. Genome Biol 2013, 14:R122. 10.1186/gb-2013-14-11-r122
14. Chen XM, Kan QC, Wang F, Kong HJ, Zhang YY, Yu WZ, Sun YP: Chromosome dynamic changes in two cultured Chinese human embryonic stem cell lines: single nucleotide polymorphism, copy number variation and loss of heterozygosity. J Cell Biochem 2012, 113:3520-3527. 10.1002/jcb.24229
15. Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S, Baharvand H, Baker J, Baker D, Munoz MB, Beil S, Benvenisty N, Ben-Yosef D, Biancotti JC, Bosman A, Brena RM, Brison D, Caisander G, Camarasa MV, Chen J, Chiao E, Choi YM, Choo AB, Collins D, Colman A, Crook JM, Daley GQ, Dalton A, de Sousa PA, Denning C, Downie J, et al.: Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol 2011, 29:1132-1144. 10.1038/nbt.2051
16. Elliott AM, Elliott KA, Kammesheidt A: High resolution array-CGH characterization of human stem cells using a stem cell focused microarray. Mol Biotechnol 2010, 46:234-242. 10.1007/s12033-010-9294-1
17. Laurent LC, Ulitsky I, Slavin I, Tran H, Schork A, Morey R, Lynch C, Harness JV, Lee S, Barrero MJ, Ku S, Martynova M, Semechkin R, Galat V, Gottesfeld J, Izpisua Belmonte JC, Murry C, Keirstead HS, Park HS, Schmidt U, Laslett AL, Muller FJ, Nievergelt CM, Shamir R, Loring JF: Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 2011, 8:106-118. 10.1016/j.stem.2010.12.003
18. Martins-Taylor K, Nisler BS, Taapken SM, Compton T, Crandall L, Montgomery KD, Lalande M, Xu RH: Recurrent copy number variations in human induced pluripotent stem cells. Nat Biotechnol 2011, 29:488-491. 10.1038/nbt.1890
19. Avery S, Hirst AJ, Baker D, Lim CY, Alagaratnam S, Skotheim RI, Lothe RA, Pera MF, Colman A, Robson P, Andrews PW, Knowles BB: BCL-XL mediates the strong selective advantage of a 20q11.21 amplification commonly found in human embryonic stem cell cultures. Stem Cell Rep 2013, 1:379-386. 10.1016/j.stemcr.2013.10.005
20. Fan Y, Luo Y, Chen X, Sun X: A modified culture medium increases blastocyst formation and the efficiency of human embryonic stem cell derivation from poor-quality embryos. J Reprod Dev 2010, 56:533-539. 10.1262/jrd.09-225M
21. Liu W, Sun X: Skewed X chromosome inactivation in diploid and triploid female human embryonic stem cells. Hum Reprod 2009, 24:1834-1843. 10.1093/humrep/dep126
22. Allen RC, Nachtman RG, Rosenblatt HM, Belmont JW: Application of carrier testing to genetic counseling for X-linked agammaglobulinemia. Am J Hum Genet 1994, 54:25-35.
23. van den Berg IM, Laven JS, Stevens M, Jonkers I, Galjaard RJ, Gribnau J, van Doorninck JH: X chromosome inactivation is initiated in human preimplantation embryos. Am J Hum Genet 2009, 84:771-779. 10.1016/j.ajhg.2009.05.003
24. Dvash T, Fan G: Epigenetic regulation of X-inactivation in human embryonic stem cells. Epigenetics 2009, 4:19-22. 10.4161/epi.4.1.7438
25. Dhara SK, Benvenisty N: Gene trap as a tool for genome annotation and analysis of X chromosome inactivation in human embryonic stem cells. Nucleic Acids Res 2004, 32:3995-4002. 10.1093/nar/gkh746
26. Hoffman LM, Hall L, Batten JL, Young H, Pardasani D, Baetge EE, Lawrence J, Carpenter MK: X-inactivation status varies in human embryonic stem cell lines. Stem Cells 2005, 23:1468-1478. 10.1634/stemcells.2004-0371
27. Kubota T, Nonoyama S, Tonoki H, Masuno M, Imaizumi K, Kojima M, Wakui K, Shimadzu M, Fukushima Y: A new assay for the analysis of X-chromosome inactivation based on methylation-specific PCR. Hum Genet 1999, 104:49-55. 10.1007/s004390050909
28. Minks J, Robinson WP, Brown CJ: A skewed view of X chromosome inactivation. J Clin Invest 2008, 118:20-23. 10.1172/JCI34470
29. Augui S, Nora EP, Heard E: Regulation of X-chromosome inactivation by the X-inactivation centre. Nat Rev Genet 2011, 12:429-442. 10.1038/nrg2987